Lo Greco, M.C.; Marano, G.; Milazzotto, R.; Liardo, R.L.E.; Finocchiaro, I.; La Rocca, M.; Basile, A.; Foti, P.V.; Palmucci, S.; David, E.;
et al. The Immunomodulatory Potential of Concurrent High-Dose Radiotherapy and Immune Checkpoint Inhibitor Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: Initial Results. J. Pers. Med. 2024, 14, 581.
https://doi.org/10.3390/jpm14060581
AMA Style
Lo Greco MC, Marano G, Milazzotto R, Liardo RLE, Finocchiaro I, La Rocca M, Basile A, Foti PV, Palmucci S, David E,
et al. The Immunomodulatory Potential of Concurrent High-Dose Radiotherapy and Immune Checkpoint Inhibitor Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: Initial Results. Journal of Personalized Medicine. 2024; 14(6):581.
https://doi.org/10.3390/jpm14060581
Chicago/Turabian Style
Lo Greco, Maria Chiara, Giorgia Marano, Roberto Milazzotto, Rocco Luca Emanuele Liardo, Irene Finocchiaro, Madalina La Rocca, Antonio Basile, Pietro Valerio Foti, Stefano Palmucci, Emanuele David,
and et al. 2024. "The Immunomodulatory Potential of Concurrent High-Dose Radiotherapy and Immune Checkpoint Inhibitor Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: Initial Results" Journal of Personalized Medicine 14, no. 6: 581.
https://doi.org/10.3390/jpm14060581
APA Style
Lo Greco, M. C., Marano, G., Milazzotto, R., Liardo, R. L. E., Finocchiaro, I., La Rocca, M., Basile, A., Foti, P. V., Palmucci, S., David, E., Pergolizzi, S., & Spatola, C.
(2024). The Immunomodulatory Potential of Concurrent High-Dose Radiotherapy and Immune Checkpoint Inhibitor Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: Initial Results. Journal of Personalized Medicine, 14(6), 581.
https://doi.org/10.3390/jpm14060581
